News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

The Medicines Company (MDCO) To Host Acute Cardiovascular Care Investor And Analyst Meeting On March 7


2/7/2014 9:51:16 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PARSIPPANY, NJ--(Marketwired - February 06, 2014) - The Medicines Company (NASDAQ: MDCO) has scheduled an acute cardiovascular care investor and analyst meeting for Friday, March 7, 2014 at the Company's Global Center 1 at 8 Sylvan Way in Parsippany, NJ. The "deep-dive" event is being hosted to review The Medicines Company's acute cardiovascular care portion of its portfolio.

The meeting will be webcast at noon eastern time and can be accessed via The Medicines Company website at www.themedicinescompany.com. Investors and Analysts interested in registration information can request by emailing investor.relations@themedco.com.

About The Medicines Company
The Medicines Company's purpose is to save lives, alleviate suffering and contribute to the economics of healthcare by focusing on 3,000 leading acute/intensive care hospitals worldwide. Its vision is to be a leading provider of solutions in three areas: acute cardiovascular care, surgery and perioperative care, and serious infectious disease care. The company operates in the Americas, Europe and the Middle East, and Asia Pacific regions with global centers today in Parsippany, NJ, USA and Zurich, Switzerland.


Contact:

Neera Dahiya Ravindran, MD
Vice President, Investor Relations & Strategic Planning
The Medicines Company
+1 (973) 290-6044
neera.ravindran@themedco.com



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES